标题
Pharmacogenomics, Lipid Disorders, and Treatment Options
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 96, Issue 1, Pages 36-47
出版商
Springer Nature
发表日期
2014-04-10
DOI
10.1038/clpt.2014.82
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metabolic Myopathies Discovered During Investigations of Statin Myopathy
- (2014) Steven K. Baker et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol
- (2014) Henry N. Ginsberg CIRCULATION RESEARCH
- Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
- (2013) Jacqueline S. Danik et al. AMERICAN HEART JOURNAL
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update
- (2013) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2013) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias
- (2013) Jennifer Fu et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
- (2013) Evan A. Stein et al. CIRCULATION
- Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care
- (2013) Marianne K. DeGorter et al. Circulation-Cardiovascular Genetics
- Genetics and Personalized Medicine—a Role in Statin Therapy?
- (2013) Jaideep Patel et al. Current Atherosclerosis Reports
- The spectrum of statin myopathy
- (2013) Payam Mohassel et al. CURRENT OPINION IN RHEUMATOLOGY
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
- (2013) Rajiv Chowdhury et al. EUROPEAN HEART JOURNAL
- Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia
- (2013) Paul Lee et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education
- (2013) Melissa Y. Wei et al. Journal of Clinical Lipidology
- Novel gene-by-environment interactions:APOBandNPC1L1variants affect the relationship between dietary and total plasma cholesterol
- (2013) Daniel S. Kim et al. JOURNAL OF LIPID RESEARCH
- RareAPOA5promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy
- (2013) Ariel Brautbar et al. JOURNAL OF LIPID RESEARCH
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
- (2013) Lara M. Mangravite et al. NATURE
- Statin myotoxicity: A review of genetic susceptibility factors
- (2013) M. Needham et al. NEUROMUSCULAR DISORDERS
- The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study
- (2013) Catherine E. de Keyser et al. Pharmacogenetics and Genomics
- Pharmacogenomics of lipid-lowering therapies
- (2013) Miao Hu et al. PHARMACOGENOMICS
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
- (2012) Jemma C. Hopewell et al. EUROPEAN HEART JOURNAL
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
- (2012) Harshal A. Deshmukh et al. JOURNAL OF LIPID RESEARCH
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study
- (2012) A C Frazier-Wood et al. PHARMACOGENOMICS JOURNAL
- Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy
- (2012) Dov Shiffman et al. PLoS One
- Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate
- (2012) Stella Aslibekyan et al. PLoS One
- Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect
- (2012) Ping Peng et al. PLoS One
- Mechanisms of statin-induced myalgia assessed by physiogenomic associations
- (2011) Gualberto Ruaño et al. ATHEROSCLEROSIS
- Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly
- (2011) Hironobu Akao et al. ATHEROSCLEROSIS
- Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses
- (2011) Stella Trompet et al. BMC Medical Genetics
- Lack of Association of KIF6 Genotype With Vascular Disease and Statin Response
- (2011) Kiran Musunuru Circulation-Cardiovascular Genetics
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy
- (2011) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
- (2010) Stefan Oswald et al. Pharmacogenetics and Genomics
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
- (2010) Mathew J. Barber et al. PLoS One
- Identification of Genetic Variants Associated With Response to Statin Therapy
- (2009) Jessica L. Mega et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- (2008) Ronald M. Krauss et al. CIRCULATION
- Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy
- (2008) Philippe Couvert et al. PHARMACOGENOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started